IMMU-53. CO-ADMINISTRATION OF DEXAMETHASONE WITH CHECKPOINT BLOCKADE THERAPY INCREASES SURVIVAL IN BRAIN TUMOR MODEL

BACKGROUND: The use of corticosteroids for therapeutic benefit must be weighed against risks of adverse consequences associated with these drugs. Brain tumor patients are routinely prescribed dexamethasone to reduce tumor-associated edema. Checkpoint blockade, a type of immune therapy, is currently...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Hutchinson, Marsha-Kay, Giles, Amber, Sonnemann, Heather, Reid, Caitlin, Park, Deric M, Gilbert, Mark R
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692480/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.511
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk